Top

Molecular and Cellular Pediatrics

Published in:

Open Access 01-12-2014 | Mini review

Cancer therapy: know your enemy?

Authors: Mike-Andrew Westhoff, Oliver Brühl, Klaus-Michael Debatin

Published in: Molecular and Cellular Pediatrics | Issue 1/2014

Abstract

Background

Most cancer therapies are devised for adult or even elder patients. However, when dealing with pediatric cancers, additional considerations are needed.

Conclusions

This review discusses non-classic components of tumors and highlights possible treatment approaches which might be of particular benefit for children and adolescents.

Available only for authorised users

Statistics of childhood cancer in the UK. Incidence, mortality and survival: , [http://www.cancerresearchuk.org/cancer-info/cancerstats/childhoodcancer/]

Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC: Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 2013, 63: 419–437. 10.3322/caac.21204CrossRef

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr: Second malignant neoplasms and cardiovascular disease following radiotherapy. Health Phys 2014, 106: 229–246. 10.1097/HP.0000000000000013CrossRef

Kim CJ, Freedman DM, Curtis RE, Berrington de Gonzalez A, Morton LM: Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers. Leuk Lymphoma 2013, 54: 1691–1697. 10.3109/10428194.2012.753543CrossRef

Westhoff MA, Bruhl O, Nonnenmacher L, Karpel-Massler G, Debatin KM: Killing me softly-future challenges in apoptosis research. Int J Mol Sci 2014, 15: 3746–3767. 10.3390/ijms15033746CrossRef

Nature milestones in cancer Nat Rev Cancer 2006, 6: S7-S23. 10.1038/nrc1786

Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144: 646–674. 10.1016/j.cell.2011.02.013CrossRef

Debatin KM, Krammer PH: Death receptors in chemotherapy and cancer. Oncogene 2004, 23: 2950–2966. 10.1038/sj.onc.1207558CrossRef

Dey P: Epigenetics meets the tumor microenvironment. Medical Epigenetics 2013, 1: 31–36. 10.1159/000354283CrossRef

10.

Barcellos-Hoff MH, Lyden D, Wang TC: The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer 2013, 13: 511–518. 10.1038/nrc3536CrossRef

11.

Kaplan RN, Rafii S, Lyden D: Preparing the "soil": the premetastatic niche. Cancer Res 2006, 66: 11089–11093. 10.1158/0008-5472.CAN-06-2407CrossRef

12.

Bissell MJ, Radisky D: Putting tumours in context. Nat Rev Cancer 2001, 1: 46–54. 10.1038/35094059CrossRef

13.

Hoelzinger DB, Demuth T, Berens ME: Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 2007, 99: 1583–1593. 10.1093/jnci/djm187CrossRef

14.

Carmona-Fontaine C, Bucci V, Akkari L, Deforet M, Joyce JA, Xavier JB: Emergence of spatial structure in the tumor microenvironment due to the Warburg effect. Proc Natl Acad Sci U S A 2013, 110: 19402–19407. 10.1073/pnas.1311939110CrossRef

15.

Pallasch CP, Leskov I, Braun CJ, Vorholt D, Drake A, Soto-Feliciano YM, Bent EH, Schwamb J, Iliopoulou B, Kutsch N, van Rooijen N, Frenzel LP, Wendtner CM, Heukamp L, Kreuzer KA, Hallek M, Chen J, Hemann MT: Sensitizing protective tumor microenvironments to antibody-mediated therapy. Cell 2014, 156: 590–602. 10.1016/j.cell.2013.12.041CrossRef

16.

Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS: Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013, 342: 967–970. 10.1126/science.1240527CrossRef

17.

Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Berard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Dore J, Kroemer G, Lepage P, et al.: The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013, 342: 971–976. 10.1126/science.1240537CrossRef

18.

Hu M, Polyak K: Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008, 18: 27–34. 10.1016/j.gde.2007.12.006CrossRef

19.

Gatenby RA, Silva AS, Gillies RJ, Frieden BR: Adaptive therapy. Cancer Res 2009, 69: 4894–4903. 10.1158/0008-5472.CAN-08-3658CrossRef

Title: Cancer therapy: know your enemy?
Authors: Mike-Andrew Westhoff
Oliver Brühl
Klaus-Michael Debatin
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: Molecular and Cellular Pediatrics / Issue 1/2014
Electronic ISSN: 2194-7791
DOI: https://doi.org/10.1186/s40348-014-0010-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Cancer therapy: know your enemy?

Abstract

Background

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Fanconi anemia: young patients at high risk for squamous cell carcinoma

Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD−/−) mice

The quest for fragile X biomarkers

Monogenic forms of childhood obesity due to mutations in the leptin gene

Matrix metalloproteinases and epileptogenesis

Proteostasis in pediatric pulmonary pathology